Castañeda-Hernández G - Search Results

1

Variability of intended copies for etanercept (Enbrel®): Data on multiple batches of seven products.

Hassett B, Scheinberg M, Castañeda-Hernández G, Li M, Rao URK, Singh E, Mahgoub E, Coindreau J, O'Brien J, Vicik SM, Fitzpatrick B. Hassett B, et al. MAbs. 2018 Jan;10(1):166-176. doi: 10.1080/19420862.2017.1387346. Epub 2017 Nov 7. MAbs. 2018. PMID: 29020508 Free PMC article.

2

Scheinberg M, Pineda C, Castañeda-Hernández G, Zarbá JJ, Damião A, Arantes LH Jr, Jacobs I. Scheinberg M, et al. MAbs. 2018 Aug/Sep;10(6):827-842. doi: 10.1080/19420862.2018.1484977. Epub 2018 Aug 29. MAbs. 2018. PMID: 30156950 Free PMC article. Review.

3

Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice.

Scheinberg M, Castañeda-Hernández G. Scheinberg M, et al. Arthritis Res Ther. 2014 Dec 6;16(6):501. doi: 10.1186/s13075-014-0501-5. Arthritis Res Ther. 2014. PMID: 25677586 Free PMC article. Review.

4

Biosimilars in rheumatology: what the clinician should know.

Castañeda-Hernández G, González-Ramírez R, Kay J, Scheinberg MA. Castañeda-Hernández G, et al. RMD Open. 2015 May 23;1(1):e000010. doi: 10.1136/rmdopen-2014-000010. eCollection 2015. RMD Open. 2015. PMID: 26509046 Free PMC article.

5

Barriers towards effective pharmacovigilance systems of biosimilars in rheumatology: A Latin American survey.

Castañeda-Hernández G, Sandoval H, Coindreau J, Rodriguez-Davison LF, Pineda C. Castañeda-Hernández G, et al. Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1035-1044. doi: 10.1002/pds.4785. Epub 2019 May 30. Pharmacoepidemiol Drug Saf. 2019. PMID: 31148288 Free PMC article. Review.

6

Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: innovators, biosimilars, and intended copies.

Castañeda-Hernández G, Szekanecz Z, Mysler E, Azevedo VF, Guzman R, Gutierrez M, Rodríguez W, Karateev D. Castañeda-Hernández G, et al. Joint Bone Spine. 2014 Dec;81(6):471-7. doi: 10.1016/j.jbspin.2014.03.019. Epub 2014 Jun 20. Joint Bone Spine. 2014. PMID: 24956990 Review.

7

Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?

Azevedo VF, Babini A, Caballero-Uribe CV, Castañeda-Hernández G, Borlenghi C, Jones HE. Azevedo VF, et al. J Clin Rheumatol. 2019 Mar;25(2):91-100. doi: 10.1097/RHU.0000000000000881. J Clin Rheumatol. 2019. PMID: 30059414 Free PMC article. Review.

8

Assessing the Immunogenicity of Biopharmaceuticals.

Pineda C, Castañeda Hernández G, Jacobs IA, Alvarez DF, Carini C. Pineda C, et al. BioDrugs. 2016 Jun;30(3):195-206. doi: 10.1007/s40259-016-0174-5. BioDrugs. 2016. PMID: 27097915 Free PMC article. Review.

9

Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product.

Halim LA, Márquez M, Maas-Bakker RF, Castañeda-Hernández G, Jiskoot W, Schellekens H. Halim LA, et al. Pharm Res. 2018 Oct 2;35(11):226. doi: 10.1007/s11095-018-2491-5. Pharm Res. 2018. PMID: 30280277 Free PMC article.

10

The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence.

Feagan BG, Marabani M, Wu JJ, Faccin F, Spronk C, Castañeda-Hernández G. Feagan BG, et al. Adv Ther. 2020 Nov;37(11):4491-4518. doi: 10.1007/s12325-020-01472-1. Epub 2020 Sep 10. Adv Ther. 2020. PMID: 32910420 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page